Ficha del valor · trimestre archivado
VRTX
Vertex Pharmaceuticals Incorporated · Healthcare · Biotechnology
23Tenedores rastreados
+1Δ titulares
112.15MAcciones mantenidas
$49.92BValor declarado
+3Nuevas posiciones
−2Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +4.5% ·
flujo de acciones -0.5% ·
nuevas posiciones netas +4.3%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 175 | -1 | 212.02M | $105.17B | +5 | −5 |
| Q1 2026 | 178 | 0 | 208.95M | $93.29B | +5 | −6 |
| Q4 2025 | 177 | -1 | 219.78M | $99.62B | +2 | −2 |
| Q3 2025 | 26 | +1 | 120.93M | $47.35B | +1 | −1 |
| Q2 2025 | 23 | +1 | 112.15M | $49.92B | +3 | −2 |
| Q1 2025 | 19 | -2 | 60.41M | $29.28B | — | −2 |
| Q4 2024 | 21 | +1 | 60.08M | $24.19B | +1 | — |
| Q3 2024 | 19 | 0 | 46.24M | $21.49B | — | — |
| Q2 2024 | 19 | — | 46.47M | $21.77B | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 28.73M | +0.7% | $12.79B | 1.9% | ▲ Add | 5 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasivo) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasivo) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasivo) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasivo) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (pasivo) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (pasivo) | 23.97M | — | $10.67B | 0.2% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 28 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 29 | BlackRock ✦ (pasivo) | 21.87M | — | $9.74B | 0.2% | n/c | 1 | SEC ↗ |
| 30 | State Street Global Advisors ✦ (pasivo) | 11.78M | -0.1% | $5.24B | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 31 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ |
| 32 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ |
| 33 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 6.41M | — | $2.85B | 0.2% | n/c | 1 | SEC ↗ |
| 37 | Geode Capital Management ✦ (pasivo) | 5.93M | +2.9% | $2.63B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 38 | Geode Capital Management ✦ (pasivo) | 5.93M | +2.9% | $2.63B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 39 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 40 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 41 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 42 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 43 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 44 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 45 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 46 | Wellington Management ✦ | 4.81M | -11.8% | $2.14B | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 47 | Norges Bank ✦ (pasivo) | 3.58M | +6.4% | $1.59B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 3.16M | +8.3% | $1.41B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 3.16M | +8.3% | $1.41B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 50 | Renaissance Technologies ✦ | 1.00M | -14.2% | $447.38M | 0.6% | ▼ Trim | 5 | SEC ↗ |
| 51 | Baillie Gifford ✦ | 212.48K | +58.0% | $94.60M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 52 | Baillie Gifford ✦ | 212.48K | +58.0% | $94.60M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 53 | Baillie Gifford ✦ | 212.48K | +58.0% | $94.60M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 54 | Baillie Gifford ✦ | 212.48K | +58.0% | $94.60M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 55 | Adage Capital Partners ✦ | 178.19K | -63.6% | $79.33M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 56 | AQR Capital Management ✦ | 141.54K | -3.0% | $62.23M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 57 | AQR Capital Management ✦ | 141.54K | -3.0% | $62.23M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 58 | AQR Capital Management ✦ | 141.54K | -3.0% | $62.23M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 59 | AQR Capital Management ✦ | 141.54K | -3.0% | $62.23M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 60 | Marshall Wace ✦ | 117.00K | -15.2% | $52.09M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 61 | Arrowstreet Capital ✦ | 61.47K | Nuevo | $27.37M | 0.0% | New | 1 | SEC ↗ |
| 62 | Tweedy, Browne ✦ | 37.25K | -2.8% | $16.59M | 1.5% | ▼ Trim | 5 | SEC ↗ |
| 63 | Bridgewater Associates ✦ | 34.39K | Nuevo | $15.31M | 0.1% | New | 1 | SEC ↗ |
| 64 | Citadel Advisors ✦ | 28.83K | +474.4% | $12.83M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 65 | Citadel Advisors ✦ | 28.83K | +474.4% | $12.83M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 66 | Fisher Asset Management ✦ | 25.75K | -16.0% | $11.47M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 67 | ARK Investment Management ✦ | 24.06K | -8.7% | $10.71M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 68 | Gotham Asset Management ✦ | 21.36K | -23.1% | $9.51M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 69 | D. E. Shaw & Co. ✦ | 20.08K | -72.1% | $8.94M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 70 | D. E. Shaw & Co. ✦ | 20.08K | -72.1% | $8.94M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 71 | GAMCO Investors ✦ | 512 | Nuevo | $227,942 | 0.0% | New | 1 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Arrowstreet Capital | $27.37M | 0.0% |
| Bridgewater Associates | $15.31M | 0.1% |
| GAMCO Investors | $227,942 | 0.0% |
Posición cerrada
| Millennium Management | $150.26M | era 0.2% |
| Two Sigma Investments | $2.00M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,678 tenedores, 225.07M acciones, $98.10B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API